BOSTON, MA
Allocation by class
Portfolio Concentration
Top 3 weight
23.5%
Top 10 weight
49.0%
Voting Authority Distribution
Total shares with voting rights: 70.95M
Full voting authority
70.95M
shares
Joint voting authority
0.00
shares
No voting authority
0.00
shares
Investment Discretion (by position count)
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DBV Technologies S ASOLE | SPONSORED ADS | 5.21M | SH | $108.91M 8.41% | 5.21M | 0.00 | 0.00 |
Cullinan Therapeutics, Inc.SOLE | Common | 7.65M | SH | $108.68M 8.39% | 7.65M | 0.00 | 0.00 |
Aktis Oncology, Inc.SOLE | Common | 4.84M | SH | $86.51M 6.68% | 4.84M | 0.00 | 0.00 |
Liquidia CorporationSOLE | Common | 1.41M | SH | $53.03M 4.10% | 1.41M | 0.00 | 0.00 |
Alumis IncSOLE | Common | 2.39M | SH | $52.58M 4.06% | 2.39M | 0.00 | 0.00 |
Edgewise Therapeutics IncSOLE | Common | 1.66M | SH | $52.31M 4.04% | 1.66M | 0.00 | 0.00 |
Revolution Medicines, Inc.SOLE | Common | 506.78K | SH | $49.28M 3.81% | 506.78K | 0.00 | 0.00 |
Agios Pharmaceuticals IncSOLE | Common | 1.31M | SH | $44.19M 3.41% | 1.31M | 0.00 | 0.00 |
Corcept Therapeutics, Inc.SOLE | Common | 985.70K | SH | $39.73M 3.07% | 985.70K | 0.00 | 0.00 |
Trevi Therapeutics IncSOLE | Common | 3.30M | SH | $39.35M 3.04% | 3.30M | 0.00 | 0.00 |
Dianthus Therapeutics IncSOLE | Common | 423.98K | SH | $35.58M 2.75% | 423.98K | 0.00 | 0.00 |
Xenon Pharmaceuticals IncSOLE | Common | 588.71K | SH | $34.23M 2.64% | 588.71K | 0.00 | 0.00 |
MoonLake ImmunotherapeuticsSOLE | Class A Ord | 1.81M | SH | $33.76M 2.61% | 1.81M | 0.00 | 0.00 |
Travere Therapeutics IncSOLE | Common | 1.13M | SH | $33.67M 2.60% | 1.13M | 0.00 | 0.00 |
Evommune IncSOLE | Common | 1.46M | SH | $33.47M 2.58% | 1.46M | 0.00 | 0.00 |
Cytokinetics IncSOLE | Common | 500K | SH | $32.95M 2.54% | 500K | 0.00 | 0.00 |
Syndax Pharmaceuticals IncSOLE | Common | 1.34M | SH | $31.32M 2.42% | 1.34M | 0.00 | 0.00 |
Context Therapeutics IncSOLE | Common | 10.68M | SH | $27.98M 2.16% | 10.68M | 0.00 | 0.00 |
Forte Biosciences, Inc.SOLE | Common | 1M | SH | $25.92M 2.00% | 1M | 0.00 | 0.00 |
Palvella Therapeutics IncSOLE | Common | 206.40K | SH | $25.73M 1.99% | 206.40K | 0.00 | 0.00 |
Dyne Therapeutics, Inc.SOLE | Common | 1.41M | SH | $25.53M 1.97% | 1.41M | 0.00 | 0.00 |
Stoke Therapeutics IncSOLE | Common | 767.04K | SH | $24.97M 1.93% | 767.04K | 0.00 | 0.00 |
Corvus Pharmaceuticals IncSOLE | Common | 1.67M | SH | $24.50M 1.89% | 1.67M | 0.00 | 0.00 |
Relay Therapeutics Inc.SOLE | Common | 2.36M | SH | $23.48M 1.81% | 2.36M | 0.00 | 0.00 |
Tarsus Pharmaceuticals IncSOLE | Common | 329.75K | SH | $23.13M 1.79% | 329.75K | 0.00 | 0.00 |